MSB 4.39% $1.09 mesoblast limited

why lots of angst.., page-6

  1. 203 Posts.
    For balance, and in case some posters haven't seen this, from the Teva website (apologies if it has been posted earlier). At least MSB gets a mention on Teva's website now. An article discussing Teva's future which mentions Revascor as a game changer:-

    Teva's future drugs

    1.Laquinimod reduces multiple sclerosis attacks. It is considered one of the most promising drugs. A request to market the drug in Europe has been submitted and it is also being tested for the treatment and prevention of other diseases, from Lupus to Alzheimer's and Parkinson's.
    2.Pridopidine for the treatment of motor deficits, among other things from Huntington's disease. The drug is in phase 3 trial.
    3.XEN402 for the treatment of severe pain. The drug is not based on opium and does not cause the side effects associated with opium-based drugs (primarily, addiction). In phase 2 trial.
    4.OGX-011 improves the efficacy of chemotherapy for prostate cancer and lung cancer. In phase 3 trial.
    5.Nuvigil for the treatment of manic-depression. A second trial did not achieve sufficiently significant results; the third trial is currently underway.
    6.Revascor for heart failure, from Australian company Mesoblast which produces drugs based on stem cells. The drug could yield sales of $2 billion a year. Teva is financing the trials, currently in phase 2, in exchange for royalties.
    7.Improved Copaxone at a dosage of 40mg, three times a week instead of daily. Phase 3 trial completed.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
-0.050(4.39%)
Mkt cap ! $1.244B
Open High Low Value Volume
$1.14 $1.17 $1.07 $8.385M 7.489M

Buyers (Bids)

No. Vol. Price($)
1 8500 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 26954 3
View Market Depth
Last trade - 16.10pm 19/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.